EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Effects of Histone Deacetylases (HDACs) in Programmed Cell Death: Execution Mechanism and Regulatory Pathways

Qi Wu, Yingjie Zhao iD, Qiuxia Yu, Jie Ding, Cheng Sun, Xin Wei, Shufang Li, Ke Wang, Renpeng Zhou, Feng Yao, Wei Hu iD

Cell Biology International · 2026

DOI: 10.1002/cbin.70105 ↗

At a glance

Übersichtsarbeit in Cell Biology International, 2026. Written by Qi Wu and 10 co-authors. Institution: Department of Clinical Pharmacology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China. Major MEDLINE topics: Histone Deacetylases, Apoptosis. 146 references. Funded by: This study was supported by National Natural Science Foundation of China (Nos. 82304505, 82371575 and 82204405)..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Histone deacetylases (HDACs) are zinc‐ or NAD + ‐dependent enzymes that play a key role in controlling diverse cellular processes by removing acetyl groups from the lysine residues of both histone and nonhistone proteins. In humans, there are 18 HDAC enzymes. Programmed cell death (PCD), which includes apoptosis, pyroptosis, ferroptosis, necroptosis, and autophagic cell death, is usually characterized by unique morphological features and energy‐dependent biochemical mechanisms involved in cellular renewal processes. In recent years, studies on HDACs and HDAC inhibitors have gradually increased because various classes of HDACs can regulate PCD through multiple signaling pathways. In this review, we focus on the specific pathways through which HDACs regulate PCD and thereby influence the development of various diseases.

Subjects

MeSH terms (MEDLINE)

Histone DeacetylasesApoptosisHumansSignal TransductionHistone Deacetylase InhibitorsAnimalsAutophagyPyroptosisFerroptosis

Author keywords

apoptosisferroptosishistone deacetylasesprogrammed cell deathpyroptosis

Substances

Histone DeacetylasesHistone Deacetylase Inhibitors

Authors and institutions

  • Department of Clinical Pharmacology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Anhui Medical University School of Pharmaceutical Sciences, Hefei, China.

ORCID profiles: Yingjie Zhao, Wei Hu

Funding

  • This study was supported by National Natural Science Foundation of China (Nos. 82304505, 82371575 and 82204405).

Cite

APA

Wu, Q., Zhao, Y., Yu, Q., Ding, J., Sun, C., Wei, X., Li, S., Wang, K., Zhou, R., Yao, F., & Hu, W. (2026). Effects of Histone Deacetylases (HDACs) in Programmed Cell Death: Execution Mechanism and Regulatory Pathways. Cell Biology International. https://doi.org/10.1002/cbin.70105

Vancouver

Wu Q, Zhao Y, Yu Q, Ding J, Sun C, Wei X, et al. Effects of Histone Deacetylases (HDACs) in Programmed Cell Death: Execution Mechanism and Regulatory Pathways. Cell Biology International. 2026. doi:10.1002/cbin.70105

BibTeX
@article{Wu2026,
  author = {Wu, Qi and Zhao, Yingjie and Yu, Qiuxia and Ding, Jie and Sun, Cheng and Wei, Xin and Li, Shufang and Wang, Ke and Zhou, Renpeng and Yao, Feng and Hu, Wei},
  title = {Effects of Histone Deacetylases (HDACs) in Programmed Cell Death: Execution Mechanism and Regulatory Pathways},
  journal = {Cell Biology International},
  year = {2026},
  doi = {10.1002/cbin.70105}
}
Start for free →